Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 49,286 shares at $125.33 ($6.2M) on 2022-11-08, disclosed to the SEC on 2022-11-10.
Open-market sale of $6.2M NBIX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.33 | 24,593 | $3.1M | 49.9% |
| 2 | $125.33 | 24,593 | $3.1M | 49.9% |
| 3 | $125.36 | 100 | $13K | 0.2% |
| Total | $125.33 avg | 49,286 | $6.2M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $503K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |